Given some of the conflicting results reported by precision medicine trials, how do you reconcile some of the divergent results and their implications for NGS-based molecular stratification?

Given some of the conflicting results reported by precision medicine trials, how do you reconcile some of the divergent results and their implications for NGS-based molecular stratification?

Given some of the conflicting results reported by precision medicine trials, how do you reconcile some of the divergent results and their implications for NGS-based molecular stratification?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jean-Charles Soria, MD

Jean-Charles Soria, MD

Professor of Medicine and Medical Oncology South-Paris University Cancer Specialist Institut Gustave Roussy (IGR) Paris, France